NO304648B1 - (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel - Google Patents
(S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddelInfo
- Publication number
- NO304648B1 NO304648B1 NO953846A NO953847A NO304648B1 NO 304648 B1 NO304648 B1 NO 304648B1 NO 953846 A NO953846 A NO 953846A NO 953847 A NO953847 A NO 953847A NO 304648 B1 NO304648 B1 NO 304648B1
- Authority
- NO
- Norway
- Prior art keywords
- alpha
- phenyl
- benzoate
- pyridinethanamine
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| PCT/GB1994/000716 WO1994022832A1 (en) | 1993-04-01 | 1994-04-05 | (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO953847D0 NO953847D0 (no) | 1995-09-28 |
| NO953847L NO953847L (no) | 1995-11-22 |
| NO304648B1 true NO304648B1 (no) | 1999-01-25 |
Family
ID=10728731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953846A NO304648B1 (no) | 1993-04-01 | 1995-09-28 | (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0691958B1 (de) |
| JP (1) | JP3023988B2 (de) |
| AT (1) | ATE156814T1 (de) |
| AU (1) | AU682350B2 (de) |
| CA (1) | CA2159480C (de) |
| DE (1) | DE69404975T2 (de) |
| DK (1) | DK0691958T3 (de) |
| ES (1) | ES2105679T3 (de) |
| FI (1) | FI109019B (de) |
| GR (1) | GR3025082T3 (de) |
| NO (1) | NO304648B1 (de) |
| WO (1) | WO1994022832A1 (de) |
| ZA (1) | ZA942140B (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
| GB9320273D0 (en) * | 1993-04-01 | 1993-11-17 | Fisons Corp | Compound useful in therapy |
| EP0356035B1 (de) * | 1988-08-12 | 1996-03-13 | Astra Aktiebolag | Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung |
| JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
| CZ288519B6 (cs) * | 1992-04-03 | 2001-07-11 | Astra Ab | (S)-alfa-Fenyl-2-pyridinethanamin, způsob jeho přípravy, farmaceutická kompozice tento enantiomer obsahující, tento enantiomer pro použití jako léčivo a použití tohoto enantiomeru pro výrobu léčiva |
-
1994
- 1994-03-25 ZA ZA942140A patent/ZA942140B/xx unknown
- 1994-04-05 WO PCT/GB1994/000716 patent/WO1994022832A1/en active IP Right Grant
- 1994-04-05 DK DK94912016.6T patent/DK0691958T3/da active
- 1994-04-05 AT AT94912016T patent/ATE156814T1/de active
- 1994-04-05 EP EP94912016A patent/EP0691958B1/de not_active Expired - Lifetime
- 1994-04-05 DE DE69404975T patent/DE69404975T2/de not_active Expired - Lifetime
- 1994-04-05 ES ES94912016T patent/ES2105679T3/es not_active Expired - Lifetime
- 1994-04-05 JP JP6521865A patent/JP3023988B2/ja not_active Expired - Lifetime
- 1994-04-05 CA CA002159480A patent/CA2159480C/en not_active Expired - Lifetime
- 1994-04-05 AU AU64337/94A patent/AU682350B2/en not_active Expired
-
1995
- 1995-09-28 NO NO953846A patent/NO304648B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954646A patent/FI109019B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402723T patent/GR3025082T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO953847D0 (no) | 1995-09-28 |
| DE69404975D1 (de) | 1997-09-18 |
| CA2159480C (en) | 2005-01-25 |
| NO953847L (no) | 1995-11-22 |
| GR3025082T3 (en) | 1998-01-30 |
| FI954646A (fi) | 1995-11-29 |
| JP3023988B2 (ja) | 2000-03-21 |
| AU6433794A (en) | 1994-10-24 |
| EP0691958A1 (de) | 1996-01-17 |
| ATE156814T1 (de) | 1997-08-15 |
| FI109019B (fi) | 2002-05-15 |
| AU682350B2 (en) | 1997-10-02 |
| ZA942140B (en) | 1994-10-03 |
| FI954646A0 (fi) | 1995-09-29 |
| DK0691958T3 (da) | 1997-12-08 |
| DE69404975T2 (de) | 1997-12-18 |
| JPH08508475A (ja) | 1996-09-10 |
| ES2105679T3 (es) | 1997-10-16 |
| WO1994022832A1 (en) | 1994-10-13 |
| EP0691958B1 (de) | 1997-08-13 |
| CA2159480A1 (en) | 1994-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063000L (no) | Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav. | |
| NO306725B1 (no) | Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler | |
| NL300258I1 (nl) | Farmaceutische samenstelling voor toepassing in debehandeling van diabetes. | |
| FI954228A (fi) | Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten | |
| ZA943744B (en) | Therapeutic substituted guanidines | |
| NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| WO1997004788A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
| MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
| NO306347B1 (no) | Eleutherobin og analoger av denne, anvendelse av forbindelsen samt farmasöytisk preparat inneholdende denne | |
| NO304647B1 (no) | (S)-alfa-fenyl-2-pyridinetanamin (S)-malat, farmas÷ytisk preparat inneholde denne forbindelsen og dens anvendelse til fremstilling av legemiddel | |
| NO304648B1 (no) | (S)-alfa-fenyl-2-pyridinetanaminbenzoat, farmasoeytisk preparat inneholdende denne forbindelsen og dens anvendelse til fremstilling av legemiddel | |
| AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
| NO306162B1 (no) | Antiandrogene forbindelser, promedikament, farmasöytisk preparat og anvendelse av forbindelsene | |
| DK0703781T3 (da) | Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom | |
| IT8821369A0 (it) | Composizione farmaceutica utile per il trattamento di malattie cardiovascolari. | |
| IT1276321B1 (it) | Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono | |
| TH29080A (th) | การบำบัดและป้องกันโรคแพนครีเอติตัส | |
| UA23119A (uk) | Психотропhий засіб | |
| ITRM920516A1 (it) | Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi. | |
| ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. | |
| DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen | |
| UA8280A (uk) | Спосіб лікування псоріазу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |